Pre-Clinical Activity of Targeting the PI3K/Akt/mTOR Pathway in Burkitt Lymphoma
Oncotarget - United States
doi 10.18632/oncotarget.25072
Full Text
Open PDFAbstract
Available in full text
Categories
Date
April 1, 2018
Authors
Publisher
Impact Journals, LLC